Sartorius Stedim Biotech Investor Relations Service

Reference Document 2014

Download pdf  (2.6 MB)

News

First-quarter Figures: Sartorius Stedim Biotech off to a dynamic start into 2015

€ in millions unless otherwise specified Unaudited figures 3 months 2015 3 months 2014 Growth in % Growth in % const. fx Order intake 224.1 175.3 27.9 17.1 Sales revenue 204.4 154.0 32.8 21.5 ...[more]

Date 20.04.2015     Category Sartorius Stedim Biotech

Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource

Takeover expands SSB’s service portfolio[more]

Date 17.04.2015     Category Sartorius Stedim Biotech

Sartorius Stedim Biotech Share (DIM)

Petra Kirchhoff

Vice President of Corporate Communications & Investor Relations

petra.kirchhoff
(at)sartorius.com
Phone: +49 551 308-1686

Andreas Theisen

Director Investor Relations

andreas.theisen
(at)sartorius.com

Phone: +49 551 308-1668